Coherus Oncology Inc
Coherus Oncology Inc (CHRS) Wheel Strategy
No qualifying wheel strategy setups were found for CHRS in the prior session.
Read more
Running a CHRS wheel strategy lets you generate consistent premium income on Coherus Oncology Inc while setting your own entry and exit prices on the underlying. Coherus Oncology Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own CHRS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best CHRS wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on CHRS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable CHRS wheel from a losing one.
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, Anti-ILT4 monoclonal antibody for solid tumors.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the CHRS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your CHRS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
No illustrative rows to display.
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →